Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Allogeneic cultured postnatal thymus-derived tissue

EU orphan designation number: EU/3/19/2137   
Active ingredient: Allogeneic cultured postnatal thymus-derived tissue
Indication: Treatment of severe combined immunodeficiency due to FOXN1 deficiency
Sponsor: Enzyvant Therapeutics Ireland Limited
88 Harcourt Street, Dublin 2 D02 DK18, Ireland

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/02/2019 Orphan designation EMA/OD/0000002979 (2019)1729 of 26/02/2019